HR Execs on the Move

Pharm-Olam

www.pharm-olam.com

 
Pharm-Olam International is a multi-national contract research organization (CRO) offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.pharm-olam.com
  • 450 N. Sam Houston Parkway E. Suite 250
    Houston, TX USA 77060
  • Phone: 713.559.7900

Executives

Name Title Contact Details
Natalie Gassen
Chief Financial Officer Profile

Similar Companies

MOLLI Surgical

#Healthcare needs to get simpler to get better. To achieve this, we focus on the #patientexperience and develop more effective #medicaldevices. #breastcancer

Trefoil Therapeutics

Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world.

Precision BioLogic

Precision BioLogic is a Dartmouth, NS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Industrial Pharmaceutical Resources

Industrial Pharmaceutical Resources is a Bartlett, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jaguar Health

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.